library.onepin.app/rg3 Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider

OnePin Peptide Library · Cognitive & Mood

Cognitive & Mood Peptide Not FDA-approved · investigational

RG3

Ginsenoside Rg3 · 20S-Ginsenoside Rg3

Ginsenoside Rg3 is a tetracyclic triterpenoid saponin found in Panax ginseng (Asian ginseng). It is one of the most pharmacologically active ginsenosides and is present in very low concentrations in raw ginseng but becomes enriched during steaming/processing (red and black ginseng). Rg3 exists in two stereoisomers - 20(S)-Rg3 and 20(R)-Rg3 - which have somewhat different biological activities. The 20(S) form is more commonly studied.,Rg3 has been extensively studied in Asian research institutions for its anti-inflammatory, metabolic, and neuroprotective properties. In China, a ginsenoside Rg3 preparation (Shenyi capsule) was approved as an adjunctive cancer therapy in 2000. Research interest has expanded to metabolic health, cognitive function, cardiovascular protection, and immune modulation. Injectable Rg3 formulations are available through compounding pharmacies in the West.,While the body of research on Rg3 is substantial (hundreds of publications), most human clinical data comes from Chinese studies, and many Western trials are still in early phases. The compound has a favorable safety profile in published studies, and its use in injectable form for metabolic and anti-inflammatory purposes has gained traction in integrative medicine practices.

Quick Start
Route
Subcutaneous (SubQ)
Start low
Per compounding pharmacy protocol
Frequency
1x daily
Timing
No specific requirement

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Quick Start
Conservative start
Per compounding pharmacy protocol · Subcutaneous (SubQ) · 1x daily
Lowest starting point. Hold about a week to assess tolerance before stepping up.
Per compounding pharmacy protocol
1x daily
Standard
Neuro-Inflammation Intranasal
1-2 sprays per nostril · Nasal · Daily
in vitro · Bae et al. 2006 (Planta Med)
1-2 sprays per nostril
Daily
Reconstitution CalculatorU-100
050100u
Draw to
units
01

How it works

Modulates multiple inflammatory pathways including NF-kB and MAPK signaling, reducing pro-inflammatory cytokine production (TNF-alpha, IL-6, IL-1beta) and oxidative stress.,Enhances insulin sensitivity and glucose metabolism through activation of AMPK and modulation of PI3K/Akt signaling, supporting metabolic health.,Exerts neuroprotective effects through reduction of neuroinflammation, promotion of neuronal survival via BDNF upregulation, and inhibition of amyloid-beta aggregation.

Modulates multiple inflammatory pathways including NF-kB and MAPK signaling, reducing pro-inflammatory cytokine production (TNF-alpha, IL-6, IL-1beta) and oxidative stress.,Enhances insulin sensitivity and glucose metabolism through activation of AMPK and modulation of PI3K/Akt signaling, supporting metabolic health.,Exerts neuroprotective effects through reduction of neuroinflammation, promotion of neuronal survival via BDNF upregulation, and inhibition of amyloid-beta aggregation.

02

What to expect

Early
Days 1–7

Days 1-7: Subtle changes in energy and inflammation. Effects build gradually.

03

Evidence

HumanPresent
AnimalPresent
In-vitroPresent
2021The Efficacy of Ginsenoside Rg3 Combined with First-line Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials · Liu X, Zhang Z, Liu J et al, Frontiers in Pharmacology ↗review
2020Ginsenoside Rg3 for Chemotherapy-Induced Myelosuppression: A Meta-Analysis and Systematic Review · Pan B, Wang Y, Wu C et al, Frontiers in Pharmacology ↗review
2008Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer · Lu P, Su W, Miao ZH et al, Chinese Journal of Integrative Medicine ↗peer reviewed
2017Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation · Wang CZ, Anderson S, Du W et al, Oncotarget ↗peer reviewed
04

Interactions & stacking

What's safe to combine, and what belongs in a separate pin.

Safe & synergistic

BPC-157Anti-inflammatory ginsenoside and tissue repair peptide have complementary but non-conflicting mechanisms
EpithalonTelomerase activation and anti-inflammatory support address different biological pathways
MelatoninAntioxidant and circadian support does not conflict with ginsenoside anti-inflammatory activity
Urolithin AMitophagy activation and anti-inflammatory ginsenoside act through independent pathways

Keep separate

Pentosan PolysulfateRG3 has mild antiplatelet activity and PPS has anticoagulant properties - combined use may increase bleeding risk
05

Pharmacokinetics

Illustrative plasma concentration · 24 h
Half-life
~3-4 hours (variable based on route and formulation)
Peak · Tmax
1-3 hours oral; 15-30 min SubQ
Elimination
~15-20 hours
Activity
12-24 hours (anti-inflammatory and metabolic effects persist beyond plasma clearance)

Storage. Store refrigerated at 2-8C. Protect from light.

06

Regulatory status

Approved as adjunctive cancer therapy in China (Shenyi capsule). Not FDA-approved in the United States. Available through compounding pharmacies as a research compound in Western countries.

Put it to work

Calculate, log & track

Open RG3 straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open RG3 in the app →

Go deeper

The guide & community

The complete RG3 walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community